0001209191-15-004435.txt : 20150115
0001209191-15-004435.hdr.sgml : 20150115
20150115164823
ACCESSION NUMBER: 0001209191-15-004435
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150113
FILED AS OF DATE: 20150115
DATE AS OF CHANGE: 20150115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 15530401
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-01-13
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Corp Controller
Common Stock
2015-01-13
4
M
0
1125
51.75
A
15312
D
Common Stock
2015-01-13
4
S
0
425
120.61
D
14887
D
Common Stock
2015-01-13
4
S
0
300
122.28
D
14587
D
Common Stock
2015-01-13
4
S
0
400
123.05
D
14187
D
Common Stock
169
I
401(k)
Stock Option (right to buy)
51.75
2015-01-13
4
M
0
1125
0.00
D
2021-07-12
Common Stock
1125
2250
D
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $120.61 (range $120.36 to $120.93).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $122.28 (range $121.83 to $122.62).
Open market sales reported on this line occurred at a weighted average price of $123.05 (range $122.87 to $123.57).
The option vests in 16 quarterly installments from 07/13/2011.
Omar White, Attorney-In-Fact
2015-01-15